- Home
- Articles
- latamerica
- eye disease
Refine by
Eye Disease Articles & Analysis
10 articles found
The corneal epithelium is the first line of defense for the eye, providing protection and contributing to the eye’s refractive properties. ...
This application is fundamental in the development of ophthalmic drugs and ensuring their safety for clinical use. Disease Modeling: The cell line aids in studying pathological conditions such as dry eye syndrome, corneal dystrophies, and infections. By replicating disease scenarios in vitro, researchers can explore the underlying mechanisms and ...
Some research data show that β-carotene from salt algae, as a new type of food additive used as a food coloring agent, can also supplement vitamin A needed by the human body, because of its scavenging of free radicals and has a strong antioxidant, anti-aging, improve learning and memory, improve vision and skin health and other efficacy. Promote Eye Health with Dunaliella ...
At present, the research hotspot is how to prepare more powerful drug preparations that can effectively control the release of drug and can be targeted for treatment. 4 Ophthalmic materials With the increasing pressure of work and study, the incidence of ophthalmologic diseases has gradually increased, and especially retinal detachment, which has become one of the most common ...
” “Similarly, multiple datasets can be compiled for federated analytics to help researchers validate the quality of a genome dataset, and leverage it for learning about a disease, without having to move sensitive information from its secure ...
ByLifebit
Founded in 2014 in California, AXIM® Biotechnologies, Inc. is a vertically integrated research and development company focused on improving the landscape for diagnosis of ophthalmological conditions such as Dry Eye Disease (DED) through rapid diagnostic tests. Additionally, it owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid ...
ByIUL S.A.
Aramis Biosciences announced that the first patient has been dosed in its phase 2 proof of concept clinical trial evaluating A197, a novel, first-in-class, topical immunomodulatory agent for the treatment of dry eye disease. “This is an important milestone for Aramis Biosciences and a hopeful moment for dry eye patients given the ...
It is a drug used to treat different types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein via intravenous and used for cancers of colon, lung, glioblastoma, and renal-cell carcinoma. This drug is used as a first-line therapy in many of these diseases. For age-related macular degeneration it is given ...
Twelve years ago Jody started getting unexplained pain, swelling and redness in her eyes after having her first child. Shortly after, she was diagnosed with Scleritis¹, a serious eye disease that is often associated with an underlying autoimmune disorder. ...
However, this approach is inadequate when considering pathogens that affect delicate organs and tissues such as the eye and nervous system. While the eye is well known as an immune-privileged organ, it remains highly susceptible to inflammatory damage. ...